Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Haemonetics Corp. (HAE)
NYSE:HAE
Holding HAE?
Track your performance easily
Earnings Data
Report Date
Feb 11, 2025TBA Not Confirmed
Period Ending
2025 (Q3)Consensus EPS Forecast
$1.17Last Year’s EPS
$1.04Same Quarter Last Year
Strong Buy
Based on 8 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 07, 2024
|% Change Since: -3.48%
|Next Earnings Date:Feb 11, 2025
Earnings Call Sentiment|Neutral
The earnings call presented strong performance in the Hospital segment and significant growth in the Vascular Closure business, which were offset by declines in Plasma and Blood Center revenues, and challenges in China. The company maintains a positive outlook with increased guidance for organic revenue growth, reflecting confidence in overcoming current challenges.Company Guidance
During Haemonetics Corporation's Q2 2025 earnings call, the company provided guidance on several key financial metrics. The executives reaffirmed their total revenue growth expectations for fiscal year 2025, projecting a range of 5% to 8% and raising their organic growth guidance to 1% to 4%, up from a previous range of flat to 3%. Plasma revenue is expected to decline by 3% to 6%, including a $100 million contribution from CSL, while the Blood Center guidance was updated to a decline of 4% to 6%, slightly better than the prior guidance of a 5% to 7% decline. The Hospital segment is anticipated to see organic revenue growth in the range of 14% to 17%, revised from 13% to 16%. Adjusted operating margin for fiscal 2025 is projected to be between 23% and 24%, with anticipated free cash flow ranging from $130 million to $180 million. Adjusted earnings per diluted share are expected to be between $4.45 and $4.75. The company also highlighted strategic investments and operational efficiencies contributing to sustainable margin improvements and reiterated their commitment to their long-range plan, focusing on profitable growth and shareholder value.Record-Breaking Hospital Revenue Growth
Hospital revenue grew 31% on a reported basis in both the second quarter and year-to-date, with organic growth of 16% and 15% respectively. Blood Management Technologies increased momentum, growing 14% in the second quarter.
VASCADE MVP XL Strong Performance
Vascular Closure grew 61% in the second quarter, driven by the successful launch of VASCADE MVP XL. The device has been introduced in nearly half of existing accounts within three months of release.
Adjusted Gross Margin Improvement
Adjusted gross margin reached 56.7%, up 270 basis points from the previous year, primarily driven by volume and mix, price contributions across all business units, and manufacturing efficiencies.
Increased Organic Revenue Growth Guidance
Total revenue growth expectation for the fiscal year is reaffirmed in the range of 5% to 8%, with an increase in organic growth guidance to 1% to 4%, up from flat to 3%.
---
HAE Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
HAE Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 07, 2024 | $78.16 | $86.53 | +10.71% |
| Aug 08, 2024 | $85.72 | $76.43 | -10.84% |
| May 09, 2024 | $93.25 | $92.60 | -0.70% |
| Feb 08, 2024 | $77.11 | $78.11 | +1.30% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Haemonetics Corp. (HAE) report earnings?
Haemonetics Corp. (HAE) is schdueled to report earning on Feb 11, 2025, TBA Not Confirmed.
What is Haemonetics Corp. (HAE) earnings time?
Haemonetics Corp. (HAE) earnings time is at Feb 11, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is HAE EPS forecast?
HAE EPS forecast for the fiscal quarter 2025 (Q3) is $1.17.
---